Starling Oncology, Inc. (STLN)

NASDAQ: STLN · Real-Time Price · USD

6.35

+0.13 (2.09%)

At close: Oct 2, 2026, 4:00 PM EDT

6.37

+0.02 (0.31%)

After-hours: Oct 2, 2026, 7:30 PM EDT

Revenue by Segment

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018
Patient Services	228.99M	204.88M	213.50M	166.79M	124.07M
Specialty Pharmacy	269.18M	179.92M	103.84M	79.34M	72.55M
Clinical Trials & Other	4.56M	8.61M	6.90M	6.36M	6.38M
Total	502.73M	393.41M	324.24M	252.48M	203.00M

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018
United States	502.73M	393.41M	324.24M	252.48M	203.00M
Total	502.73M	393.41M	324.24M	252.48M	203.00M